JUBEL REED: Open Payments
NPI 1659423556 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 15 payments from 7 companies in 2025. Trend: 2023 $713 · 2024 $348 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Lilly USA, LLC | 3 | $64 |
| Exact Sciences Corporation | 3 | $56 |
| Novo Nordisk Inc | 2 | $43 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Abbott Laboratories | 1 | $17 |
Products named: Cologuard Collection Kit, FARXIGA, Saxenda, MOUNJARO, BREZTRI, JARDIANCE, NP Thyroid 60, CAPLYTA.
Industry payments across TX — which companies pay providers there.
